Cargando…

Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma

Antidiabetic medication may modify the incidence of hepatocellular carcinoma (HCC). We aimed to compare the use of different antidiabetic strategies and the incidence of HCC. PubMed, Embase.com and Cochrane Library databases were searched up to 31 October 2015 and randomized controlled trials (RCTs)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yao-Yao, Zhu, Gui-Qi, Liu, Tian, Zheng, Ji-Na, Cheng, Zhang, Zou, Tian-Tian, Braddock, Martin, Fu, Shen-Wen, Zheng, Ming-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027387/ https://www.ncbi.nlm.nih.gov/pubmed/27642100 http://dx.doi.org/10.1038/srep33743

Ejemplares similares

Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
por: Zhou, Yao-Yao, et al.
Publicado: (2016)

Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Systematic Review and Network Meta-Analysis of Randomized Controlled Trials: Comparative Effectiveness and Safety of Direct-Acting Antiviral Agents for Treatment-Naive Hepatitis C Genotype 1
por: Zhu, Gui-Qi, et al.
Publicado: (2016)

Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection
por: Huang, Gui-Qian, et al.
Publicado: (2017)

Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection
por: Huang, Gui-Qian, et al.
Publicado: (2015)

Systematic Review With Network Meta-Analysis: Adjuvant Chemotherapy for Resected Colorectal Liver Metastases
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis
por: Guan, Ming-Cheng, et al.
Publicado: (2023)

Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

A network meta-analysis of the efficacy and side effects of udca-based therapies for primary sclerosing cholangitis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis
por: Tian, Guo, et al.
Publicado: (2018)

Effects of first‐line antidiabetic drugs on the improvement of arterial stiffness: A Bayesian network meta‐analysis
por: Wang, Jincheng, et al.
Publicado: (2023)

Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma
por: Cui, Tian-ming, et al.
Publicado: (2020)

ATF3 inhibits the tumorigenesis and progression of hepatocellular carcinoma cells via upregulation of CYR61 expression
por: Chen, Cong, et al.
Publicado: (2018)

Antidiabetic Effect and Mode of Action of Cytopiloyne
por: Chang, Cicero Lee-Tian, et al.
Publicado: (2013)

Clinical stages of recurrent hepatocellular carcinoma: A retrospective cohort study
por: Yao, Si-Yang, et al.
Publicado: (2021)

The transcription factor FOXN3 inhibits cell proliferation by downregulating E2F5 expression in hepatocellular carcinoma cells
por: Sun, Ji, et al.
Publicado: (2016)

Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis
por: Zhu, Gui-Qi, et al.
Publicado: (2015)

Reduced expression of miR-30c-5p promotes hepatocellular carcinoma progression by targeting RAB32
por: He, Zheng, et al.
Publicado: (2021)

Safety and effectiveness of multi-antenna microwave ablation-oriented combined therapy for large hepatocellular carcinoma
por: Zhang, Tian-qi, et al.
Publicado: (2019)

A Novel Antidiabetic Monomers Combination Alleviates Insulin Resistance Through Bacteria-Cometabolism-Inflammation Responses
por: Han, Lin, et al.
Publicado: (2020)

Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection
por: Huang, Sha, et al.
Publicado: (2015)

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
por: Qu, Wei-Feng, et al.
Publicado: (2023)

Derivate Isocorydine (d-ICD) Suppresses Migration and Invasion of Hepatocellular Carcinoma Cell by Downregulating ITGA1 Expression
por: Liu, Xiaoqin, et al.
Publicado: (2017)

The pre- and postoperative nomograms to predict the textbook outcomes of patients who underwent hepatectomy for hepatocellular carcinoma
por: Xie, Gui-Lin, et al.
Publicado: (2023)

Cancer-Associated Fibroblasts from Hepatocellular Carcinoma Promote Malignant Cell Proliferation by HGF Secretion
por: Jia, Chang-Chang, et al.
Publicado: (2013)

Systematic review with network meta-analysis: Comparative efficacy of oral nucleos(t)ide analogues for the prevention of chemotherapy-induced hepatitis B virus reactivation
por: Zhang, Min-Yue, et al.
Publicado: (2016)

Biomarkers for hepatocellular carcinoma based on body fluids and feces
por: Guan, Ming-Cheng, et al.
Publicado: (2021)

The pretreatment lymphocyte to monocyte ratio predicts clinical outcome for patients with hepatocellular carcinoma: A meta-analysis
por: Song, Wei, et al.
Publicado: (2017)

Radiomics for preoperative prediction of early recurrence in hepatocellular carcinoma: a meta-analysis
por: Tian, Huan, et al.
Publicado: (2023)

Upregulating KTN1 promotes Hepatocellular Carcinoma progression
por: Pan, Jian, et al.
Publicado: (2021)

Prognostic Role of C-Reactive Protein in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zheng, Zhiyun, et al.
Publicado: (2013)

Suppression of epithelial-mesenchymal transition in hepatocellular carcinoma cells by Krüppel-like factor 4
por: Li, Qi, et al.
Publicado: (2016)

Multi-parameter gene expression profiling of peripheral blood for early detection of hepatocellular carcinoma
por: Xie, Hui, et al.
Publicado: (2018)

Antidiabetic Effects of Tea
por: Fu, Qiu-Yue, et al.
Publicado: (2017)

Prognostic significance of postoperative change of PALBI grade for patients with hepatocellular carcinoma after hepatectomy
por: Wang, Zheng-Xia, et al.
Publicado: (2021)

Prognostic prediction models for oropharyngeal squamous cell carcinoma (OPSCC): a protocol for systematic review, critical appraisal and meta-analysis
por: Lu, Zhen, et al.
Publicado: (2023)

Nonglycemic Outcomes of Antidiabetic Medications
por: Morse, Christopher, et al.
Publicado: (2019)

Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis
por: Lan, Tian, et al.
Publicado: (2016)

Oncogenic tuftelin 1 as a potential molecular-targeted for inhibiting hepatocellular carcinoma growth
por: Wu, Meng-Na, et al.
Publicado: (2021)

Preoperative Prediction Power of Imaging Methods for Microvascular Invasion in Hepatocellular Carcinoma: A Systemic Review and Meta-Analysis
por: Huang, Jiacheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hc323n8jr6p7jotqcv4afeii9d